Analyst Targets for RTX Diverge: Raised to $240, Lowered by Others
Recent analyst reports on RTX (Raytheon Technologies) show a split narrative, with one research firm raising its price target to $240 while others lower theirs, and the model fair value unchanged at $215.27 per share. The divergence reflects some analysts focusing on product opportunities like the PW1100G Section Plus upgrade, while others take a more cautious view.
Key Numbers
Recent analyst reports on RTX (Raytheon Technologies) reveal a clear divergence in views. One research firm raised its price target to $240, while other analysts lowered their targets, and the model fair value remains unchanged at $215.27 per share.
Recommendation Change
One research firm raised its price target for RTX from a previous level to $240, while other analysts reduced their targets. The previous target for the raising firm was not disclosed. The model fair value of $215.27 remains unchanged.
Analyst Rationale
Analysts who raised their target cite product opportunities, such as the PW1100G Section Plus engine upgrade, which could boost revenues in the commercial aviation segment. In contrast, analysts who lowered their targets adopt a more cautious stance, possibly due to concerns about costs, demand, or macroeconomic factors.
Context
The divergence comes amid mixed recent performance for RTX stock. Some analysts are optimistic about the company's ability to capitalize on demand for engine upgrades and maintenance, while others believe current valuations may not fully reflect risks. Recent stock performance was not detailed in the source.
What to Make of It
The analyst split reflects uncertainty about RTX's near-term outlook. Investors are advised to monitor upcoming quarterly reports and product developments to form an informed view, rather than relying on any single recommendation.
Frequently Asked Questions
Found this useful? Share it